EGF mutant receptor vIII as a molecular target in cancer therapy.

in Endocrine-Related Cancer
View More View Less
  • 1 Department of Pathology, Duke University Medical Center, Durham, North Carolina 27710, USA.

If the inline PDF is not rendering correctly, you can download the PDF file here.

 

Society for Endocrinology

Sept 2018 onwards Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 746 123 13
PDF Downloads 461 132 16